NOTE: The American Society of Regional Anesthesia (ASRA) guidelines had to be removed in July 2024 at the behest of ASARA.
(before giving me a low review consider that ASRA (and their attorneys) see a copy right infringement in using a published guideline)
Guidelines from the University Hospital of Basel, Switzerland have been added and the Austrian Guidleines updated.

修正一些問題

Minor changes and improvements

New ESAIC and AWMF guidelines, better presentation if GFR reduced

data for renal insufficiency is again visible

Dark mode, adapted for new guidelines (changes in ASRA, divided heparin into iv and sc), small bug fixes

Adapted timing and bridging. Printouts and emails are formatted. Update of Information on substance groups including antagonism with Andexanet Alfa and Idarucizumab, respectively.

Optimizing for iPhone 8/8plus and iPhone X

minor bug fixes

Traduzione in italiano (Grazie tanto Gianmaria Bernasconi!)
Comment on monitoring Dabigatran with thrombin time
Comment on Xa decoy

optimised for iOS 10
stability improvement
preliminary information on recombinant FXa decoy

Still attacking the 'crash at launch' ! Please send me feedback if you experience an issue.
Added a warning about renal insufficiency in LMWH
Added the specific dalteparin antagonist idarucizumab in group description.

New user interface, side menu is replaced with a toolbar. Search on home screen, 3D touch for 6s (plus)
Hopefully the crash on app open is gone, otherwise please email me.
Should CoaguSafe crash after the update, then please delete the app and re-install.

first implementation of iOS 9 spotlight search
added Edoxaban (Lixiana, Savaysa)

update according to ASRA draft guidelines
*** please note: *** this might be one of the last updates for iOS 7

twitter integration for feedback (see settings tab)

small bug fixes
adapted at iPhone 6
the features 'bridging' and 'cardiovascular risk' are - if not used - reminded.

fixed a wrong pausing
minor bug fixes
added option to switch app language

**** please rate this app - with comment or just with the stars. Easy via settings.
thank you

New with the German guidelines (DGAI) published in september 2014.
Layout adapted to iPhone 6
Minor bug fixes

Most important first: now also for iPad !

small bug fixes
bleeding risk: Comment on the increased risk of neuraxial anesthesia.

Corrected some localization issues in the German version.

Link for rating is now working correctly - please rate...  Thank you !
Minor bug fixes
Changed english localization ('suspend' instead of 'pause') - thanks to my english friends!
New simple help screen can be activated in the index page

Completely new version, new layout, added information.
Most important changes:
- user can chose between different guidelines
- new oral anticoagulants are paused according to renal function
- new information on drug classes

Please... please... rate the app on iTunes - Thank you

Neues Design.
Fehlerkorrekturen beim LMWH
Korrekturen der Berechnung des thromboembolischen Risikos.
Verschiedene kleinere Anpassungen.
Medikamente können jetzt auch nach Firmennamen angezeigt werden.

Fondaparinux ist neu bei den Faktor Xa Antagonisten.
Fehlerkorrekturen beim Bridging.